Klotho Neurosciences has a quick ratio of 83.59. It generally indicates good short-term financial strength.
The historical rank and industry rank for Klotho Neurosciences's Quick Ratio or its related term are showing as below:
KLTO'
s Quick Ratio Range Over the Past 10 Years
Min: 0.03 Med: 0.29 Max: 135.65
Current: 83.59
During the past 4 years, Klotho Neurosciences's highest Quick Ratio was 135.65. The lowest was 0.03. And the median was 0.29.
KLTO's Quick Ratio is not ranked
in the Biotechnology industry.
Industry Median: 3.6
vs KLTO: 83.59
Klotho Neurosciences (NAS:KLTO) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Klotho Neurosciences Quick Ratio Related Terms
Klotho Neurosciences Quick Ratio Historical Data
* Premium members only.
The historical data trend for Klotho Neurosciences's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Klotho Neurosciences's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Klotho Neurosciences Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Klotho Neurosciences's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Klotho Neurosciences's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Klotho Neurosciences's Quick Ratio for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Klotho Neurosciences (KLTO) has a Quick Ratio of 83.59 as of Sep. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Klotho Neurosciences and its competitors. This is 28724% above median its historical median of 0.29. Over the past decade, Klotho Neurosciences' Quick Ratio has ranged from 0.03 to 135.65.
Is Klotho Neurosciences' Quick Ratio too high?
Klotho Neurosciences' current Quick Ratio of 83.59 is 28724% above median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 135.65. The Biotechnology industry median Quick Ratio is 3.60. Klotho Neurosciences' value of 83.59 is 2221.9% above this industry median. Overall, Klotho Neurosciences has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Klotho Neurosciences' Quick Ratio compare to KTTA and JUNS?
Klotho Neurosciences' Quick Ratio of 83.59 can be compared against companies in the Biotechnology industry. The industry median Quick Ratio is 3.60. Klotho Neurosciences' value of 83.59 is 2221.9% above this benchmark. Historically, Klotho Neurosciences' own Quick Ratio has ranged from 0.03 to 135.65 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 3.60, Klotho Neurosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,416 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Klotho Neurosciences's current Quick Ratio of 83.59 is 2221.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Klotho Neurosciences and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Klotho Neurosciences's current Quick Ratio is 83.59, which is 28724% above median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Klotho Neurosciences stock overvalued right now?
Klotho Neurosciences (KLTO) has a current Quick Ratio of 83.59. The current Quick Ratio is 83.59, which is 28724% above median its 10-year median of 0.29 and 2221.9% above the Biotechnology industry median of 3.60. Klotho Neurosciences' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Klotho Neurosciences (KLTO), the current Quick Ratio is 83.59 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
22GF Score
Get the complete analysis for KLTO
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KLTO has been successfully added to your 
